Life Sciences Knowledge Hub

​About LSKH

Life Sciences Knowledge Hub is focused on the application of chemistry, biology and materials science to the discovery, development, formulation, manufacture and commercialization of pharmaceuticals, biotherapeutics, diagnostics and other supporting products and services within the life sciences sector.

The magazine is published online, with print issues being produced for distribution at industry events. The total readership is about 25,000 life sciences executives, with about 40% of these based in Europe, 40% based in the USA, and 20% based in Asia (mainly in India, China and Japan). This readership is comprised of middle- and senior-level managers in companies specializing in fine chemicals, contract manufacture, formulation, small-molecule therapeutics (from start-ups to Big Pharma), biotechnology (from technology platform developers through contract manufacture to biotherapeutics companies), diagnostics, clinical development, clinical trials management and (bio)pharmaceutical commercialization, as well as in companies providing life sciences support services.

A unique opportunity

Working in partnership with Bio Integrates we have created a unique opportunity to engage with the biotech industry before, during and after the event. We will be offering the opportunity to submit editorials, interviews and video interviews. (see below examples)

Orgenesis – Cell and gene therapies are becoming well established as effective methods for treating disease:

Helsinn – Anticancer API facility:

Companies will be working closely with our experienced editor Tom Mulligan. Tom is a qualified industrial chemist with more than 30 years of international experience in B2B publishing including chemical, pharmaceutical, biotechnology and related vertical markets. He is also a former director of highly successful technical and business strategy conferences in the pharmaceutical chemistry and biotechnology sectors.

The topics that we are looking to cover for this special issue will be following the three tracks:

  • Track one Connection – Finding the right investors, partners and vendors is key to accelerating the development and commercialisation of new products. How do you make the best connections?
  • Track two Reflection – 2020 was an unprecedented year. What impact has it had on biotech funding, pipelines and ecosystem?
  • Track three Projection – What does the future hold for life science investment and infrastructure?

This is a key opportunity to build relationship and trust and to directly engage with the audience and potential client ahead of the event.

Preparation is key… so don’t miss the opportunity to be seen and to see what’s hot in the biotech industry ahead of the event, mail  to register your interest.